
|Articles|November 18, 2021
Pharmacy Clinical Pearl of the Day: Endometrial Cancer
Author(s)Saro Arakelians, PharmD
Treatment for endometrial cancer includes surgery, radiation therapy, chemotherapy, immunotherapy, and supportive care.
Advertisement
Clinical Pearl of the Day: Endometrial Cancer
Endometrial cancer is a type of the disease that begins in the uterus.
Insight:
- The uterus is the hollow, pear-shaped pelvic organ where fetal development occurs.
- Symptoms include vaginal bleeding after menopause, bleeding between periods, and pelvic pain.
- Risk factors include changes in the hormone balances, menstruation starting before 12 years of age, never being pregnant, older age, obesity, hormone therapy for breast cancer, and history of colon cancer.
- Diagnosis includes examining the pelvis, using sound waves to create a picture of the uterus, scoping the endometrium, sample biopsy, and performing surgery
- Treatment for endometrial cancer includes surgery, radiation therapy, chemotherapy, hormone therapy, targeted drug therapy, immunotherapy, and supportive care.
- Some of the chemotherapy medications for endometrial cancer paclitaxel (Taxol), carboplatin, doxorubicin (Adriamycin), cisplatin and docetaxel (Taxotere).
Sources:
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
2
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
3
Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market
4
The Return of Belantamab Mafodotin: Past Lessons, Present Promise, and Future Impact
5
















































































































































































































